Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

被引：0

作者：

Arnaud Bayle

Laila Belcaid

Lola-Jade Palmieri

Diego Teysonneau

Sophie Cousin

Mariella Spalato-Ceruso

Mihaela Aldea

Damien Vasseur

Melissa Alame

Laura Blouin

Isabelle Soubeyran

Claudio Nicotra

Maud Ngocamus

Antoine Hollebecque

Yohann Loriot

Benjamin Besse

Ludovic Lacroix

Etienne Rouleau

Fabrice Barlesi

Fabrice Andre

Antoine Italiano

机构：

[1] DITEP,Department of Oncology

[2] Gustave Roussy,Department of Medicine

[3] Copenhagen University Hospital,Department of Medicine

[4] Institut Bergonié,Department of Biopathology

[5] Gustave Roussy,Department of Biopathology

[6] Gustave Roussy,Faculty of Medicine

[7] Institut Bergonié,Faculty of Medicine

[8] Paris Saclay University,undefined

[9] University of Bordeaux,undefined

来源：

Molecular Cancer | / 22卷

关键词：

ctDNA; Targeted therapy; Resistance biomarkers; Next-generation sequencing;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 40 条

[1] Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study
Bayle, Arnaud
Belcaid, Laila
Palmieri, Lola-Jade
Teysonneau, Diego
Cousin, Sophie
Spalato-Ceruso, Mariella
Aldea, Mihaela
Vasseur, Damien
Alame, Melissa
Blouin, Laura
Soubeyran, Isabelle
Nicotra, Claudio
Ngocamus, Maud
Hollebecque, Antoine
Loriot, Yohann
Besse, Benjamin
Lacroix, Ludovic
Rouleau, Etienne
Barlesi, Fabrice
Andre, Fabrice
Italiano, Antoine
MOLECULAR CANCER, 2023, 22 (01)
[2] Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM)
Bayle, Arnaud
Belcaid, Laila
Cousin, Sophie
Palmieri, Lola-Jade
Spalato, Mariella
Aldea, Mihaela
Vasseur, Damien
Alame, Melissa
Soubeyran, Isabelle
Nicotra, Claudio
Ngocamus, Maud
Ponce, Santiago
Loriot, Yohann
Besse, Benjamin
Lacroix, Ludovic
Rouleau, Etienne
Oxnard, Geoffrey R.
Barlesi, Fabrice
Andre, Fabrice
Italiano, Antoine
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[3] Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
Bayle, A.
Belcaid, L.
Aldea, M.
Vasseur, D.
Peyraud, F.
Nicotra, C.
Geraud, A.
Sakkal, M.
Seknazi, L.
Cerbone, L.
Blanc-Durand, F.
Hadoux, J.
Mosele, F.
Tagliamento, M.
Bernard-Tessier, A.
Verret, B.
Smolenschi, C.
Clodion, R.
Auger, N.
Romano, P. M.
Gazzah, A.
Camus, M. N.
Micol, J.
Caron, O.
Hollebecque, A.
Loriot, Y.
Besse, B.
Lacroix, L.
Rouleau, E.
Ponce, S.
Soria, J. C.
Barlesi, F.
Andre, F.
Italiano, A.
ANNALS OF ONCOLOGY, 2023, 34 (04) : 389 - 396
[4] Clinical utility of circulating tumor DNA sequencing with a large panel: The experience of Gustave Roussy/ National Center for Precision Medicine (PRISM)
Bayle, Arnaud
Belcaid, Laila
Aldea, Miha
Peyraud, Florent
Romano, Patricia Martin
Blanc-Durand, Felix
Clodion, Rebecca
Ponce, Santiago
Nicotra, Claudio
Hollebecque, Antoine
Loriot, Yohann
Besse, Benjamin
Vasseur, Damien
Lacroix, Ludovic
Rouleau, Etienne
Soria, Jean-Charles
Barlesi, Fabrice
Oxnard, Geoffrey R.
Andre, Fabrice
Italiano, Antoine
CANCER RESEARCH, 2022, 82 (12)
[5] Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes
Cecchini, Michael
Walther, Zenta
Sklar, Jeffrey L.
Bindra, Ranjit S.
Petrylak, Daniel P.
Eder, Joseph P.
Goldberg, Sarah B.
LANCET ONCOLOGY, 2018, 19 (01): : 23 - 24
[6] Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients
Shim, Hyoeun
Kwon, Min Jeong
Park, In Hae
Kim, Min Kyeong
Cho, Eun-Hae
Lee, Junnam
Lee, Seung-Tae
Sim, Sung Hoon
Lee, Keun Seok
Kim, Yun-Hee
Kim, Seok-Ki
Lee, Eun Sook
Kong, Sun-Young
ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
[7] Circulating tumor DNA as a prognostic biomarker in pancreatic cancer patients treated with FOLFIRINOX: A prospective cohort study
Chun, J.
Han, N.
Kim, M.
Lee, D.
Park, H.
Han, S.
Park, S.
Kim, T.
Lee, W.
Kim, Y.
Kong, S.
Woo, S.
ANNALS OF ONCOLOGY, 2022, 33 : S319 - S319
[8] Systematic comparison of ctDNA vs tissue sequencing with a large panel to guide therapy in patients with advanced cancer: A study from the French National Center for Precision Medicine (PRISM)
Bayle, Arnaud
Peyraud, Florent
Belcaid, Laila
Brunet, Maxime
Aldea, Miha
Clodion, Rebecca
Dubos, Paul
Vasseur, Damien
Nicottra, Claudio
Ponce, Santiago
Soubeyran, Isabelle
Khalifa, Emmanuel
Loriot, Yohann
Besse, Benjamin
Lacroix, Ludovic
Rouleau, Etienne
Oxnard, Geoffrey
Barlesi, Fabrice
Andre, Fabrice
Italiano, Antoine
CANCER RESEARCH, 2022, 82 (12)
[9] Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer
Topham, James T.
O'Callaghan, Chris J.
Feilotter, Harriet
Kennecke, Hagen F.
Lee, Young S.
Li, Weimin
Banks, Kimberly C.
Quinn, Katie
Renouf, Daniel J.
Jonker, Derek J.
Tu, Dongsheng
Chen, Eric X.
Loree, Jonathan M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 485 - +
[10] Circulating Tumor DNA for Noninvasive Monitoring of Non-Small Cell Lung Cancer Patients Receiving EGFR-Targeted Therapies
Tsui, Dana
Muhammed, Murtaza
Wong, Alvin S. C.
Rueda, Oscar M.
Forshew, Tim
Soo, Ross
Wong, H. I.
Goh, Boon Cher
Eisen, Tim
Marass, Francesco
Gale, Davina
Liu, Wei
Chin, Tan Min
Rosenfeld, Nitzan
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S358 - S359

← 1 2 3 4 →